Rationality of Antibiotic Use on Pneumonia Patients at dr. Doris Sylvanus Hospital Palangkaraya in 2022

Nawan; Farah Annisa; Septi Handayani; Mual BE Parhusip; Dewi Furtuna; Adelgrit Trisia; Agnes I Toemon

doi:10.28932/jmh.v7i1.8586

Authors

Nawan Department of Microbiology, Faculty of Medicine, University of Palangka Raya
Farah Annisa Faculty of Medicine, University of Palangka Raya, Kalimantan Tengah
Septi Handayani Department of Biochemistry, Faculty of Medicine, University of Palangka Raya
Mual BE Parhusip Department of Pulmonology, Faculty of Medicine, University of Palangka Raya
Dewi Furtuna Department of Microbiology, Faculty of Medicine, University of Palangka Raya
Adelgrit Trisia Department of Pediatrics, Faculty of Medicine, University of Palangka Raya
Agnes I Toemon Department of Parasitology, Faculty of Medicine, University of Palangka Raya

DOI:

https://doi.org/10.28932/jmh.v7i1.8586

Keywords:

pneumonia, antibiotic, defined daily dose, gyssens criteria

Abstract

Pneumonia can be defined as a condition when a microorganism triggers inflammation of the lung parenchyma. The bronchioles and alveoli will be filled with inflammatory leukocyte exudate and fluid, causing respiratory difficulties and symptoms such as coughing, dyspnea, chest pain, and shock in severe cases. Pneumonia infections caused by bacteria can be treated with antibiotics. Bacterial patterns and sensitivity test results available at the hospital are used as a guide in selecting empiric therapy given to patients. Diagnostic limitations in differentiating viral and bacterial pathogens in pneumonia have led to increased use of antibiotics and contributed to the growth of antibiotic resistance. This research aims to determine the rationality of antibiotic use in pneumonia patients' resistance at RSUD dr.Doris Sylvanus Palangka Raya in 2022. A descriptive observational approach using a cross-sectional method was used to examine the medical records of pneumonia patients. Antibiotics commonly used by patients diagnosed with pneumonia at RSUD dr.Doris Sylvanus Palangka Raya in 2022 is Moxifloxacin with 153 patients (22.53%), then Levofloxacin with 143 patients (21.06%), and Ceftriaxone with 137 patients (20.18%). The total defined daily dose/100 days of antibiotics for pneumonia patients is 88.85 and according to the Gyssens criteria, the use of antibiotics is 82.62% rational.

Downloads

References

Seramo R. Kumdin, Awol SM, Wabe YA, Ali M. Determinants of pneumonia among children attending public health facilities in Worabe town. Sci Rep 2022;12(1); 6175

Sibuea F, Hardhana B, Widiantini W. Profil Kesehatan Indonesia 2021. KEMENKES RI 2022;1-289.

Dinas Kesehatan Provinsi Kalimatan Tengah. Profil Dinas Kesehatan Provinsi Kalimantan Tengah Tahun 2019. 2020; 1-129.

Sitompul PA, Indriani R, Rusli A, Sundari T, Rosamarlina, Hartono TS, et al. Antimicrobial Sensitivity Pattern from Hospitalized Pneumonia Patients in National Referral Infectious Disease Hospital in Indonesia. Adv Med 2022;2022:1–5

Nawan, Isnaeni, Wasito EB. Antimicrobial Activity of Streptomyces sp. Isolated from Acidic Peatlands against Extended Spectrum Beta Lactamase (ESBL) producing Escherichia coli. Res J Pharm Technol 2020;13(3):1121–6

Tarigan GE, Nawan N, Toemon AI. Identification and Resistance Testing of Bacteria Causing Nosocomial Infections in Surgery Inpatient Rooms. Dis Prev Publ Health Journ. 2023;17(1):100–8

Hossain MJ, Jabin N, Ahmmed F, Sultana A, Abdur Rahman SM, Islam MR. Irrational use of antibiotics and factors associated with antibiotic resistance: Findings from a cross-sectional study in Bangladesh. Health Sci Rep 2023;6(8); e1465

Vaughn VM, Gandhi TN, Chopra V, Petty LA, Giesler DL, Malani AN, et al. Antibiotic Overuse After Hospital Discharge: A Multi-hospital Cohort Study. Clin Infect Dis 2021;73(11): E4499–506

Siahaan S, Herman MJ, Fitri N. Antimicrobial Resistance Situation in Indonesia: A Challenge of Multisector and Global Coordination. J Trop Med 2022;2022;1-10

Siahaan S, Rukmini R, Roosihermiatie B, Andarwati P, Handayani RS, Tarigan IU, et al. The Effort to Rationalize Antibiotic Use in Indonesian Hospitals: Practice and Its Implication. J Trop Med 2023; 2023; 1-12

Norwegian Institute of Public Health. Guidelines for ATC Classification and DDD Assignment 27th Edition. (Bakken GV. ed). WHO Collaborating Centre for Drug Statistics Methodology; 2024; 1-251.

Andrajati R, Tilaqza A, Supardi S. Factors related to rational antibiotic prescriptions in Depok City, Indonesia community health centers. J Infect Public Health 2017;10(1):41–8.

Krishnakumar J, Tsopra R. What rationale do GPs use to choose a particular antibiotic for a specific clinical situation? BMC Fam Pract 2019;20(1); 1-9.

Harrison JE, Weber S, Jakob R, Chute CG. ICD-11: an international classification of diseases for the twenty-first century. BMC Med Inform Decis Mak 2021;21(6):1–10.

Yusuf M, Auliah N, Sarambu HE. Evaluasi Penggunaan Antibiotik dengan Metode Gyssens pada Pasien Pneumonia di Rumah Sakit Bhayangkara Kupang Periode Juli – Desember 2019. Jurnal Riset Kefarmasian Indonesia 2022;4(2):215–9.

Corica B, Tartaglia F, D’Amico T, Romiti GF, Cangemi R. Sex and gender differences in community-acquired pneumonia. Intern Emerg Med 2022;17(6):1575.

Teramoto S. The current definition, epidemiology, animal models and a novel therapeutic strategy for aspiration pneumonia. Respir Investig 2022;60(1):45–55.

Dewi TP, Dhirisma F. Penggunaan Antibiotika pada Pasien Dewasa Pneumonia dengan Metode DDD (Defined Daily Dose) di Rawat Inap RSU PKU Muhammadiyah Bantul Periode Tahun 2019. Jurnal Kefarmasian Akfarindo 2021;8–13.

Brar RK, Jyoti U, Patil RK, Patil HC. Fluoroquinolone antibiotics: An overview. Adesh University Journal of Medical Sciences & Research 2020;2(1):26–30.

Lin X, Kück U. Cephalosporins as key lead generation beta-lactam antibiotics. Appl Microbiol Biotechnol 2022;106(24):8007–20.